{"nct_id":"NCT04661007","title":"To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2020-12-15","start_date_type":"ACTUAL","primary_completion_date":"2026-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}